World-leading experts in MDS shared the top abstracts from the 62nd American Society Hematology (ASH) Annual Meeting and Exposition that they believed could have the greatest impact on clinical practice.
Did you miss ASH 2020? In this downloadable resource, we present comments from MDS Hub Steering Committee members on improving the treatment of patients with low- and high-risk MDS, as well as improving the diagnosis/prognosis in MDS.